We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Final Guidance on Data Monitoring Committees
FDA Issues Final Guidance on Data Monitoring Committees
April 5, 2006
The FDA has issued final guidance on how clinical trial sponsors should establish data monitoring committees (DMCs) to enhance protection of trial participants when safety concerns are unusually high (CTA, Jan. 12, Page 3).